Company Profiles

driven by the PitchBook Platform

Archer Pharmaceuticals

Description

Developer of drugs for Alzheimer’s disease. The company is engage din the research and development of Nilvadipine as a therapeutic for Alzheimer’s Disease.

2008

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$150k

Latest Deal Amount

$2.7M

Total Amount Raised

Description

Developer of drugs for Alzheimer’s disease. The company is engage din the research and development of Nilvadipine as a therapeutic for Alzheimer’s Disease.

Website:

www.archerpharma.com

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

2040 Whitfield Avenue Sarasota, FL 34243United States +1 (941) 755-6644
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Archer Pharmaceuticals's full profile, request a free trial.

Archer Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Archer Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Archer Pharmaceuticals Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Jerry SmithChief Financial Officer
Fiona Crawford Ph.DChief Technology Officer & Associate Chief Scientific Officer
Jerry Smith Chief Financial Officer
Fiona Crawford Ph.D Chief Technology Officer & Associate Chief Scientific Officer
Request full access to PitchBook